Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson's disease
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on the risk of spontaneous intracerebral hemorrhages after blood transfusions; the burden of long distance travel to see neurologists; and two promising biomarkers for early diagnosis of Parkinson's disease.
2 Nov 20234min
Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer's
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on blood pressure targets for stroke after endovascular therapy, changing policies on CME, and a direct-to-consumer blood test for Alzheimer's disease.
19 Okt 20234min
Football and Parkinson's, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new research on football and the risk for Parkinson's disease, the potential of deep brain stimulation for recovery from stroke, and neuroprostheses for patients with anarthria.
5 Okt 20234min
Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses the Medicare's proposed coverage of carotid stenting in asymptomatic patients,neuro-oncologists' perspectives on a federal initiative to target persistent poverty in vulnerable patients, and the technological promise of a new optical EMG for neuromuscular disorders.
21 Sep 20235min
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses research that assesses the safety of endovascular treatment post-stroke for people with intracranial tumors, the AANEM guideline on IVIG use for neuromuscular disorders, and the latest data on donanemab.
7 Sep 20235min
Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that associate poor oral health and risk for cognitive decline and how to manage first-ever sleep seizures that recur as well as the growth of concierge neurology.
17 Aug 20234min
Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses studies that identify gene variants associated with MS severity/progression, an AI program that read EEGs accurately, and butylphthalide as a promising neuroprotective agent for ischemic stroke.
3 Aug 20235min
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a novel therapeutic approach that induced antigen tolerance in an MS mouse model, the association between epileptiform activity and ICU outcomes, and an agent, vorasidenib, that slows low-grade gliomas.
20 Juli 20235min
